Reviewed by Dr. Shradha Chakhaiyar, MS (OB-GYN), MRCOG (London), IVF Specialist
📋 Table of Contents
- What Is a Fresh Embryo Transfer?
- What Is a Frozen Embryo Transfer (FET)?
- The Science of Vitrification
- Why FET Often Outperforms Fresh
- What the Research Actually Shows
- The 2025 Reversal — When Fresh Is Better
- OHSS — The Medical Case for Freeze-All
- The Doctor’s Decision Framework
- Cycle Timelines Compared
- The Freeze-All Protocol
- Baby Health Outcomes
- How We Decide at Shradha IVF, Patna
What Is a Fresh IVF Cycle?
A fresh embryo transfer is when the embryo created during your IVF cycle is transferred to your uterus in the same cycle — typically 5 days after egg retrieval, once it reaches the blastocyst stage — without any freezing. The egg retrieval, fertilisation, embryo development, and uterine transfer all happen within a single menstrual cycle, usually over 3–4 weeks. A frozen embryo transfer (FET) means the embryo is vitrified (flash-frozen) after development and transferred in a separate, later cycle after the uterus has been independently prepared. Fresh transfer is the original IVF approach — the way IVF was performed for its first decades. Embryos are created and transferred in one continuous process. The advantage is speed: if your embryos are healthy and your body is ready, you can move from egg retrieval to transfer within the same week.
Fresh transfer was the original IVF approach — the way every IVF cycle was performed for the first two decades of the technique. Embryos were retrieved, fertilised, cultured for 3–5 days, and transferred while still in the same stimulation cycle. Speed was the primary advantage: the whole process from first injection to transfer takes about 3–4 weeks, and the two-week wait begins almost immediately after retrieval.
Fresh transfer remains a valid, evidence-supported option in 2026 — but it is no longer the default for most patients, and understanding why the recommendation has shifted requires understanding what happens to the uterus during ovarian stimulation.
What Is a Frozen Embryo Transfer (FET)?
A frozen embryo transfer (FET) is when embryos created during an IVF cycle are cryopreserved (frozen) using a technique called vitrification, and then thawed and transferred to the uterus in a subsequent cycle — typically 4–8 weeks later, after the body has recovered from stimulation.
In a frozen embryo transfer, the embryos created during your stimulation cycle are vitrified (ultra-rapidly frozen) and stored in liquid nitrogen at –196°C immediately after they reach the blastocyst stage. They are not transferred to that cycle. In a subsequent menstrual cycle — typically 4–8 weeks later — your uterus is prepared with oestrogen support to build an optimal endometrial lining, and the thawed embryo is transferred once the lining reaches the right thickness and timing.
The critical distinction is this: in a fresh cycle, the stimulation and the transfer happen in the same hormonal environment. In a FET cycle, they are completely separate events — the ovaries are allowed to recover from stimulation before the uterus is prepared for implantation. As you will understand after reading this guide, separation is the biological foundation for FET’s clinical advantages.
What is Vitrification & Why Modern Freezing Is Not What You Fear?
Most patients’ hesitation about frozen cycles comes from a reasonable but outdated fear: “Won’t freezing damage the embryo?” In the early days of IVF cryopreservation, the answer was sometimes yes. The old technique — slow-rate cooling — allowed water molecules inside the embryo cells to form ice crystals as they froze, causing structural damage. Embryo survival rates after thawing with slow freezing were 60–75%.
Vitrification, developed in the early 2000s, works entirely differently. The embryo is first dehydrated by replacing cellular water with cryoprotectant solution, then plunged into liquid nitrogen at a rate of 20,000°C per minute — so fast that the water molecules have no time to crystallise. Instead, they solidify in a glass-like (vitreous) state with no ice crystal formation at all. The result: embryo survival rates after thawing now consistently exceed 95–98% at quality embryology laboratories. In practical terms, this means that when a blastocyst is frozen at Shradha IVF, the overwhelming probability is that it will thaw perfectly intact on the day of transfer.
Vitrification has not just improved frozen cycle outcomes — it has made the freeze-all strategy safe enough to become the primary IVF approach at many leading clinics worldwide. The fear of “ruining” embryos by freezing them is a legitimate concern about 2005 technology. In 2026, it is not a meaningful clinical risk at a quality laboratory. [INTERNAL LINK: IVF Treatment page]
Fresh vs Frozen — A Complete Comparison Table
The Biological Foundation — Why Uterine Receptivity Favours FET for Most Patients
To understand why frozen cycles often produce better outcomes, you need to understand what ovarian stimulation does to the uterus — and it is rarely explained clearly.
The Window of Implantation — Your Body’s Precision Timing System
The endometrial lining is only receptive to embryo implantation during a narrow, precisely timed “window of implantation” — estimated to be approximately 24–48 hours in each cycle, occurring around days 19–21 of a natural 28-day cycle. Outside this window, the lining actively rejects embryos. This window is determined by a precise sequence of oestrogen and progesterone signalling that coordinates the opening and closing of implantation receptivity.
During IVF ovarian stimulation, the ovaries are driven by high doses of FSH injections to produce 8–15 (or more) follicles simultaneously. This generates oestrogen levels 5–10× higher than a natural cycle. These supraphysiological oestrogen levels can do one of two things to the implantation window: close it prematurely, or shift it forward by 1–2 days — so that by the time the embryo reaches the uterus on Day 5, the window has already been open and is beginning to close. The embryo arrives late to a lining that is already transitioning out of its receptive phase.
This is not speculation — it is a well-documented phenomenon in IVF research, particularly in cases where progesterone levels rise prematurely during the stimulation phase (so-called “premature luteinisation”), which occurs in approximately 10–15% of standard stimulation cycles. When progesterone rises too early, the lining’s molecular receptivity profile shifts — and a fresh transfer into that lining produces consistently lower implantation rates than a FET in a separately prepared cycle.
The FET Cycle — Resetting the Lining Independently
In a frozen transfer cycle, the uterus is prepared completely independently of the stimulation that created the embryos. Typically, oestrogen tablets or patches are given for 12–14 days to build the endometrial lining to the optimal thickness (minimum 7–8 mm, ideally 9–11 mm). Progesterone support is then introduced for exactly 5–6 days before transfer, creating a precisely timed, hormonally clean environment for implantation.
Critically, there is no supraphysiological oestrogen from stimulation, no premature progesterone rise, and the window of implantation can be controlled far more reliably than in a fresh cycle, where the timing is dictated by the stimulation response. The embryo is transferred into a lining that was prepared specifically and exclusively for it — not one that has just been through a week of intense ovarian stimulation.
What the Research Actually Shows — Success Rates and Key Studies
The evidence on fresh versus frozen cycles has developed significantly over the past decade. Here is what the best quality research shows in 2026:
OHSS — The Medical Reason Your Doctor May Strongly Recommend Freeze-All
If your doctor has told you to freeze all embryos and you were not expecting this recommendation, the OHSS risk is the most likely reason. Understanding OHSS — what it is, how it happens, and why freeze-all prevents it from becoming dangerous — will help you understand why this is not a setback but a protective decision.
What Is OHSS and Why Does It Happen?
Ovarian Hyperstimulation Syndrome is the ovaries’ excessive response to the stimulation medications used in IVF. When too many follicles develop simultaneously, the ovaries become enlarged and release inflammatory mediators — primarily VEGF (vascular endothelial growth factor) — that cause blood vessels to become leaky, allowing fluid to shift from the bloodstream into the abdominal cavity and chest. This causes bloating, abdominal pain, nausea, and in moderate-to-severe cases, significant fluid accumulation that can cause breathing difficulties and require hospitalisation.
Mild OHSS affects up to 20–30% of IVF cycles. Moderate-to-severe OHSS affects 2–3% of cycles and requires medical management. In rare severe cases, OHSS can cause blood clots, kidney failure, and life-threatening complications.
Why Pregnancy Makes OHSS Dramatically Worse
The critical reason freeze-all is recommended when the OHSS risk is high is this: pregnancy worsens OHSS. Human chorionic gonadotropin (HCG) — the pregnancy hormone produced from the moment of implantation — acts on the same ovarian receptors as the stimulation trigger, amplifying the VEGF response and dramatically escalating the syndrome. A mild-to-moderate OHSS that would have resolved in 7–10 days without pregnancy can become severe OHSS lasting 4–6 weeks when a fresh transfer results in pregnancy.
Freeze-all breaks this cycle entirely. By freezing all embryos and not performing a fresh transfer, the ovaries are allowed to recover naturally over one cycle. The OHSS resolves. The following frozen cycle uses only oestrogen and progesterone support — no stimulation — so the OHSS risk is eliminated before the embryo is transferred. This is why the Cochrane 2025 data shows OHSS risk dropping from 3% to 1% with freeze-all: the danger is structurally removed from the process.
PCOS in Bihar — Why This Section Matters Locally
PCOS is the single most common infertility diagnosis at fertility clinics across Bihar, UP, and Jharkhand — partly because PCOS prevalence in India is high (1 in 5 women), and partly because diagnosis is often delayed by years. Women with PCOS are at the highest risk of OHSS during IVF stimulation because their ovaries typically contain a large number of antral follicles (AFC often 15–30+) that all respond to stimulation simultaneously.
The Doctor’s Decision Framework — Who Gets Fresh, Who Gets FET
This is the table most IVF patients actually need. It synthesises the 2025 evidence into a clear clinical decision framework:
Cycle Timelines — What Each Approach Looks Like Week by Week
The main practical trade-off is clear: fresh transfer is faster by 4–8 weeks. For some couples — particularly those who are older and for whom time is a premium — this speed advantage is clinically meaningful and should be weighed explicitly with their specialist.
Cost Comparison — Fresh Cycle vs FET in India
FET is significantly less expensive than a full IVF cycle because the costly egg retrieval and stimulation phase has already been completed. For couples with frozen embryos from a previous IVF cycle, FET represents an affordable pathway to a subsequent pregnancy attempt.
What to Expect During Each Cycle
Fresh Transfer Timeline
- Day 1–10: Ovarian stimulation injections
- Day 10–12: Egg retrieval under anaesthesia (day care)
- Day 13–17: Fertilisation, embryo development in lab
- Day 15–18: Fresh embryo transfer (Day 3 or Day 5 blastocyst)
- Day 25–30: Pregnancy test
Frozen Transfer Timeline
- Stimulation cycle: Egg retrieval + fertilisation + vitrification (no transfer)
- 1–2 months rest / recovery
- Prepared FET cycle: Oestrogen tablets for 12–14 days to build the lining
- Ultrasound to confirm lining thickness (minimum 7mm)
- Progesterone support begins 5–6 days before transfer
- Transfer of thawed embryo — typically day 5 blastocyst
- Pregnancy test 10–12 days after transfer
Total time from stimulation to FET transfer: typically 6–10 weeks.
The Freeze-All Protocol — When Every Embryo Is Banked Before Any Transfer
A growing subset of IVF cycles uses what is called a “freeze-all” or “elective freeze-all” protocol: rather than making a transfer decision embryo-by-embryo, all embryos from a stimulation cycle are vitrified before any transfer is attempted. The FET follows in a subsequent cycle.
Freeze-all is used proactively — as a planned strategy from the beginning — in the following situations:
- Women with PCOS and anticipated high ovarian response (AFC >15)
- All cycles where PGT-A preimplantation genetic testing is planned
- Women whose stimulation produces very high oestrogen levels (>3,500 pg/mL)
- Cycles where progesterone rises above 1.5–2.0 ng/mL before the trigger
- Women undergoing “embryo banking” — accumulating embryos from multiple cycles before any transfer attempt (common in women with low ovarian reserve who want to maximise their embryo pool)
Freeze-all is increasingly considered the standard of care at leading IVF centres — not a fallback when something goes wrong, but the first-choice strategy that separates stimulation optimisation from transfer optimisation. At Shradha IVF, we evaluate the decision proactively at the start of every cycle, not reactively on the day of retrieval. [INTERNAL LINK: ICSI page]
What About the Baby? — Health Outcomes for FET vs Fresh Transfer Children
This is one of the most frequently asked — and least well-answered — questions about frozen embryo transfer. Parents understandably want to know whether freezing an embryo affects their child’s health. The research is reassuring:
- Birth weight: Multiple studies, including the JAMA 2018 RCT, found that babies born from frozen embryo transfers have higher average birth weight than those from fresh transfer. FET babies are less likely to be born with low birth weight (<2,500g). This is likely related to the better uterine environment created by the prepared FET cycle — improved placental development and more optimal hormonal conditions during early pregnancy.
- Preterm birth: FET births consistently show lower rates of preterm delivery than fresh transfer births in multiple large studies. Preterm birth is one of the leading causes of neonatal morbidity — so this is a clinically meaningful advantage for FET babies.
- Metabolic health: A 2025 study specifically evaluating metabolic outcomes (blood pressure, glucose metabolism, body composition) in children born from FET versus fresh transfer found no significant differences between the groups. The concern that FET babies might have higher metabolic disease risk — raised by some earlier studies — has not been confirmed in well-designed prospective research.
- Congenital anomalies: The available evidence does not show an increased risk of birth defects in vitrified-embryo transfers compared to fresh transfers or natural conception.
In summary, FET babies are at least as healthy as fresh transfer babies, and likely to be born slightly heavier and at term more often. The freezing process itself, done with modern vitrification, does not harm the embryo in any clinically measurable way.
How We Decide at Shradha IVF — Bihar-Specific Context
From Dr. Shradha Chakhaiyar, IVF Specialist, Patna: In my practice in Patna, the most common patient profile I see is a woman with PCOS — often diagnosed late, often with AMH levels suggesting high ovarian reserve and a correspondingly high OHSS risk. For this patient, the freeze-all recommendation is not a conservative preference — it is a medically essential decision to prevent OHSS from escalating if pregnancy occurs. I have seen, at other centres, PCOS patients who had fresh transfers and developed severe OHSS that required hospitalisation — an entirely preventable complication. The freeze-all strategy, followed by a well-prepared FET cycle, gives this patient both safety and the best uterine environment for implantation. That combination of safety and optimised outcomes is the standard I hold every cycle at Shradha IVF.
At the other end of the spectrum, when I have a patient with very low ovarian reserve — retrieving 4–6 eggs, AMH below 0.5 — I now think seriously before recommending freeze-all after the 2025 BMJ data. For her, the fresh transfer may be the genuinely better clinical choice. Every cycle, every patient is evaluated individually. There is no universal protocol that is right for everyone.
At Shradha IVF, the decision between fresh and frozen is discussed openly with every couple before the stimulation cycle begins — not made for them on the day of retrieval. You will always know the reasoning, the evidence behind it, and the alternatives.
FAQs related to fresh vs frozen embryo transfer
Both frozen embryo transfer (FET) and fresh transfer can be effective, but many clinics now prefer FET because it allows the body to recover and creates a more natural uterine environment. Studies often show similar or slightly higher success rates with frozen transfers, depending on individual health and treatment conditions.
Both 4AA and 5AA embryos are high-quality blastocysts with excellent chances of implantation. A 5AA embryo is slightly more expanded than 4AA, indicating further development, but both grades are considered top quality. Success ultimately depends on multiple factors like uterine health and overall fertility condition.
IVF success with fresh or frozen eggs can be comparable, especially with modern freezing techniques like vitrification. Frozen eggs provide flexibility and are useful for fertility preservation, while fresh eggs may sometimes offer slightly higher success depending on age and egg quality at the time of retrieval.
For women over 40, frozen embryo transfer is often preferred because it allows better preparation of the uterine lining and reduces hormonal stress. However, success largely depends on egg quality, embryo health, and overall medical condition, so treatment is always personalised.
